Issued Patents All Time
Showing 26–50 of 99 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11618788 | Optimized antibodies that target CD19 | Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +2 more | 2023-04-04 |
| 11584794 | Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragments | Rumana Rashid, John Desjarlais, Rajat Varma, Christine Bonzon | 2023-02-21 |
| 11566080 | Compositions and methods for treating IgE-mediated disorders | John Desjarlais, Seung Chu, Holly M. Horton | 2023-01-31 |
| 11524991 | PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof | John Desjarlais, Rumana Rashid, Rajat Varma, Christine Bonzon | 2022-12-13 |
| 11512122 | IL-7-FC-fusion proteins | John Desjarlais, Suzanne Schubbert, Christine Bonzon, Rajat Varma, Raphael Clynes | 2022-11-29 |
| 11505595 | TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domains | John Desjarlais, Rumana Rashid, Rajat Varma, Christine Bonzon | 2022-11-22 |
| 11492407 | Bispecific checkpoint inhibitor antibodies | Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon, Alex Nisthal +1 more | 2022-11-08 |
| 11377477 | PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof | John Desjarlais, Michael Hedvat, Suzanne Schubbert, Christine Bonzon, Rumana Rashid +1 more | 2022-07-05 |
| 11358999 | IL-12 heterodimeric Fc-fusion proteins | John Desjarlais, Rajat Varma, Ke Liu, Nargess Hassanzadeh-Kiabi, Rumana Rashid | 2022-06-14 |
| 11352412 | CTLA4-IG immunoadhesins | Gregory Alan Lazar | 2022-06-07 |
| 11352442 | Heterodimeric antibodies that bind CD3 and CD38 | Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal | 2022-06-07 |
| 11319355 | Engineered IL-2 Fc fusion proteins | John Desjarlais, Rajat Varma, Rumana Rashid | 2022-05-03 |
| 11312770 | Bispecific and monospecific antibodies using novel anti-PD-1 sequences | Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon, Alex Nisthal +1 more | 2022-04-26 |
| 11254727 | CTLA4-Ig immunoadhesins | Gregory Alan Lazar | 2022-02-22 |
| 11236170 | Bispecific checkpoint inhibitor antibodies | Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon, Alex Nisthal | 2022-02-01 |
| 11225528 | Heterodimeric antibodies that bind CD3 and tumor antigens | Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2022-01-18 |
| 11111315 | Heterodimeric antibodies that bind CD3 and tumor antigens | Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2021-09-07 |
| 11091548 | Modulation of T cells with bispecific antibodies and Fc fusions | Seung Chu, Dilki Wickramarachichi, John Desjarlais | 2021-08-17 |
| 11084863 | Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains | John Desjarlais, Rajat Varma, Suzanne Schubbert, Juan Diaz | 2021-08-10 |
| 11053316 | Optimized antibody variable regions | Gregory Moore, Rumana Rashid, John Desjarlais | 2021-07-06 |
| 10981992 | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors | Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon | 2021-04-20 |
| 10968276 | Optimized anti-CD3 variable regions | Gregory Moore, Rumana Rashid, John Desjarlais | 2021-04-06 |
| 10913803 | Heterodimeric antibodies that bind CD3 and tumor antigens | Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2021-02-09 |
| 10889653 | Heterodimeric antibodies that bind CD3 and tumor antigens | Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2021-01-12 |
| 10858417 | Heterodimeric proteins | Gregory Moore, Rumana Rashid, John Desjarlais | 2020-12-08 |